We are live on ! Find out more
AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $309B
1-Year Est. Return 23.92%
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Fund
S&P 500
This Quarter Est. Return
+2.44%
1 Year Est. Return
+23.92%
3 Year Est. Return
+92.38%
5 Year Est. Return
+118.97%
10 Year Est. Return
+515.32%
AUM
$116B
AUM Growth
-$1.52B
Cap. Flow
-$3.02B
Cap. Flow %
-2.6%
Top 10 Hldgs %
14.61%
Holding
3,089
New
175
Increased
1,565
Reduced
960
Closed
125

Top Buys

Rank Stock Value
1
HP icon
Helmerich & Payne
HP
+$323M
2
XOM icon
ExxonMobil
XOM
+$286M
3
SLB icon
SLB Ltd
SLB
+$256M
4
SPGI icon
S&P Global
SPGI
+$234M
5
JNJ icon
Johnson & Johnson
JNJ
+$197M

Sector Composition

Rank Sector Weight
1 Healthcare 14.88%
2 Technology 14.65%
3 Financials 14.29%
4 Consumer Discretionary 10.3%
5 Industrials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARAV
2851
DELISTED
Aravive, Inc. Common Stock
ARAV
$142K ﹤0.01%
+2,133
New +$121K
CCXI
2852
DELISTED
ChemoCentryx, Inc.
CCXI
$142K ﹤0.01%
+31,700
New +$119K
VTAE
2853
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$140K ﹤0.01%
+13,000
New +$111K
WAC
2854
DELISTED
Walter Investment Mgt Corp
WAC
$139K ﹤0.01%
50,299
+5,800
+13% +$31.3K
MEET
2855
DELISTED
The Meet Group, Inc. Common Stock
MEET
$139K ﹤0.01%
+26,000
New +$96.5K
LCTX icon
2856
Lineage Cell Therapeutics
LCTX
$269M
$137K ﹤0.01%
60,122
+4,115
+7% +$10.1K
GEN
2857
DELISTED
Genesis Healthcare, Inc.
GEN
$137K ﹤0.01%
77,126
+4,200
+6% +$8.57K
RGLS
2858
DELISTED
Regulus Therapeutics
RGLS
$136K ﹤0.01%
393
+208
+112% +$149K
OCUL icon
2859
Ocular Therapeutix
OCUL
$1.89B
$135K ﹤0.01%
27,300
+15,300
+128% +$152K
ZGNX
2860
DELISTED
Zogenix, Inc.
ZGNX
$133K ﹤0.01%
16,512
+2,400
+17% +$23.4K
SREV
2861
DELISTED
ServiceSource International, Inc.
SREV
$130K ﹤0.01%
32,220
+12,000
+59% +$47.6K
COOP
2862
DELISTED
Mr. Cooper
COOP
$129K ﹤0.01%
+4,833
New +$133K
SFE
2863
DELISTED
Safeguard Scientifics, Inc.
SFE
$129K ﹤0.01%
+10,330
New +$139K
PSG
2864
DELISTED
Performance Sports Group Ltd.
PSG
$128K ﹤0.01%
42,500
-300
-0.7% -$993
TBBK icon
2865
The Bancorp
TBBK
$2.73B
$126K ﹤0.01%
20,900
+3,000
+17% +$18.1K
TUBE
2866
DELISTED
TubeMogul, Inc.
TUBE
$126K ﹤0.01%
+10,600
New +$134K
TVIX
2867
DELISTED
VelocityShares Daily 2x VIX Short Term ETN
TVIX
$126K ﹤0.01%
+2
New +$163K
DX
2868
Dynex Capital
DX
$2.98B
$125K ﹤0.01%
5,983
+2,500
+72% +$50.4K
MRTX
2869
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$125K ﹤0.01%
+22,900
New +$365K
AVHI
2870
DELISTED
A V Homes, Inc.
AVHI
$125K ﹤0.01%
+10,260
New +$121K
GNRT
2871
DELISTED
Gener8 Maritime, Inc.
GNRT
$125K ﹤0.01%
+19,500
New +$138K
LWAY icon
2872
Lifeway Foods
LWAY
$465M
$124K ﹤0.01%
12,815
MITK icon
2873
Mitek Systems
MITK
$715M
$124K ﹤0.01%
+17,400
New +$130K
COLL icon
2874
Collegium Pharmaceutical
COLL
$1.15B
$122K ﹤0.01%
+10,300
New +$170K
EC icon
2875
Ecopetrol
EC
$33.6B
$122K ﹤0.01%
12,774
+268
+2% +$2.49K

Similar funds

AllianceBernstein's Q2 2016 Portfolio in Review

As of Q2 2016, AllianceBernstein held 3,089 positions worth $116B, down 1.3% from $118B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

AllianceBernstein's Q2 2016 filing shows 175 new, 1,565 increased, 960 reduced and 125 closed positions. Its largest new stake was S&P Global: 2,177,315 shares worth $234M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $436M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

  • AllianceBernstein's largest Q2 2016 buy was S&P Global: 2,177,315 shares worth $234M.
  • AllianceBernstein added most to Helmerich & Payne in Q2 2016, an estimated $323M increase.
  • AllianceBernstein's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $436M.
  • AllianceBernstein fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $251M.
  • AllianceBernstein's ten largest holdings make up 15% of its $116B portfolio in Q2 2016.
  • AllianceBernstein opened 175 new positions and closed 125 in Q2 2016.
  • AllianceBernstein's portfolio value fell 1.3% quarter-over-quarter to $116B.

Based on AllianceBernstein's 13F filing for Q2 2016, filed 11 Aug 2016.